Polymerase Chain Reaction (PCR) Technologies and Global Markets

Report Highlights

The global market for polymerase chain reaction (PCR) is estimated to increase from $9.1 billion in 2023 to reach $12.6 billion by 2028, at a compound annual growth rate (CAGR) of 6.7% from 2023 through 2028.

Report Includes

• 49 data tables and 65 additional tables
• An overview and up-to-date analysis of the global markets for the polymerase chain reaction (PCR) technologies
• Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
• Estimate of the actual market size and revenue forecast for the PCR markets in USD millions, and corresponding market share analysis based on product, technique, application, and region
• In-depth information (facts and figures) pertaining to the major market dynamics, R&D efforts, current status on MedTech, upcoming technologies, future demand in clinical diagnostics, and regulatory scenarios; and the impacts of COVID-19 pandemic on the worldwide market
• Identification of the companies that are best positioned to meet the surging demand for innovations in PCR technology, owing to or in conjunction with their proprietary technologies, strategic alliances, and other competitive advantages
• Discussion of sustainability trends and factors in emerging materials in the PCR market, with emphasis on consumer attitudes, ESG score analysis, future of ESG, and the ESG practices followed
• An overview of the major vendors in the global PCR market along with an analysis of the structure of the industry, including company market shares and recent mergers and acquisitions (M&A) activity
• Review of both new and existing patents on PCR technologies and their applications in molecular diagnosis of infectious diseases
• Profiles of the leading global players, including F. Hoffmann-LaRoche, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Becton, Dickinson and Company, and Danaher Corp.

Report Scope

This research study analyzes the PCR market, offers revenue forecasts, assesses future trends, and provides strategic recommendations for the success of market participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and forecasts for 2023 through 2028. Figures for 2023 are estimated, except where actual results are reported. This report includes forecasts by product type, technique, application, and region from 2023 through 2028. 

The report also analyzes leading and emerging competitors in the current worldwide PCR market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.